Tuesday, June 16, 2020 2:33:28 PM
Anders, My enthusiasm for, and dreams of, NWBO are based on 10 years+ of published/PR interim (not muddy) data validated by 69 renown experts in the field. With regard to my expectations of exceptional returns, this is based on the number of GBM patients multiplied by the treatment cost. An industry multiplier is added. See a summary of the interim data along Abeta’s market cap chart for the details, below.
------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------
When you take into consideration (1) the numbers of GBM patients in the US, the UK and germany, (2) multiplied by the treatment costs and (3) add the industry multiplier (5x,7x or 10x), even with sub par market penetration rates (even though DCVAX-L will be SOC), the market cap will be multiples of your $6 billion estimate. Here's the link to abeta's market cap chart: https://investorshub.advfn.com/uimage/uploads/2019/3/1/iyjxeMARKET_CAP_OPTUNE_VS_VAX.jpg
Now to your points:
1. "But what is superb...", "With superb I mean to what the medical community perceives as superb" ROTFLMAO!! Your position is disingenuous, and you know it, which is why you have to change the definition of your own words. ARE YOU SERIOUS...ROTFLMAO!!
So first you quoted SOS and than intentionally misrepresented what he said to fit your BS. I called you out on it https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156297429).
Now you have nowhere to go except to say "Superb" is not "Superb". Well, Here is what you said:
Ok let's assume the science is solid and the(OS) TLD results are superb.
Merriam-Webster's Definition of superb
: marked to the highest degree by grandeur, excellence, brilliance, or competence
Free Dictionary's Definition of superb: Of unusually high quality; excellent:
Cambridge Dictionary's Definition of superb : of excellent quality; very great
Anders2211's definition of Superb : (1) Who the hell knows; (2) it's however Exwannabe defines it... AFTER I USED THE TERM.
A second SAP doesn't smell at all...unless you believe the trial isn't blinded..."wink, wink"...lol. NWBO has repeatedly and consistently stated it is blinded and there is no evidence, anywhere or by anyone at all, that even slightly suggest otherwise. You are pulling these issues out of your @zz to support you bs.
Muddy data?!?!? Really. the only thing muddy is the bs you spout without support. Your statement regarding SOS was intentionally manipulated. SOS implied the opposite of what you stated, you changed you definition of "superb" because with the common definition you can not justify your position. Now, you throw in "muddy data" without one bit of evidence to support the claim DESPITE THE INTERIM DATA PUBLISHED IN A JOURNAL, SIGNED BY 69+ RENOWNED EXPERTS IN THE FIELD.
2. "Superb results or modest results its all about the to be catered target group." So "Superb" TLD is now "modest" TLD. Objective scientific data reviewed and validated by a reputable journal and 69+ renown experts in the field can now be subjectively perceived by, or catered to, a target group. Really? Here, imho, you revealed your true thoughts/intentions in a way that you did not intend. You are taking objective data and bastardized it to fit you bs position without even an attempt to support it. "Muddy data" my @zz! Can you say, "Freudian slip"? ROTFLMAO!!!!!!
Your statement: "SOS has always argued that he sees L approved so your argument between superb and plain data being translated in the MC is absolute BS. Approval is approval after that comes the to be catered market." What!?!?! ROTFLMAO...again. Let's just look at the original conversation:
Anders, you know you tried to use a quote from SOS to support your position. You said,
If TLD is presented and results are superb or considered really well I expect the MC to get somewhere over 1 billion
If the market perceived that DCVax-L had a reasonable chance for approval, analysis of peer companies suggests that the market capitalization could be well in excess of $1 billion.
3. nwbo doesn't need DIRECT to reach 3/4 times your estimate.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
